Mary Guilfoyle, MS
Cofounder, VP, Strategic Ops
Expertise
35 years at major pharma co with extensive experience leading compound development teams
Former Compound Development Team Leader, Janssen; Led hematology (PROCRIT/EXPREX) & oncology (Velcade, Doxil, & Sylvant) teams through approvals
Advisor, Every Cure, UPenn
9 peer-reviewed publications
15 Janssen Leadership awards; Castleman Disease Collaborative Network Community Leadership Achievement Award 2017
MS, University of Rochester
BS, Rutgers University
